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Abstract
Background: Previous studies have reported an association between sun exposure and improved cutaneous
melanoma (CM) survival. We analysed the association of UV exposure with prognostic factors and outcome in a
large melanoma cohort.
Methods: A questionnaire was given to 289 (42%) CM patients at diagnosis (Group 1) and to 402 CM patients (58%)
during follow-up (Group 2). Analyses were carried out to investigate the associations between sun exposure and
melanoma prognostic factors and survival.
Results: Holidays in the sun two years before CM diagnosis were significantly associated with lower Breslow
thickness (p=0.003), after multiple adjustment. Number of weeks of sunny holidays was also significantly and
inversely associated with thickness in a dose-dependent manner (p=0.007). However when stratifying by gender this
association was found only among women (p=0.0004) the risk of CM recurrence in both sexes was significantly lower
in patients (n=271) who had holidays in the sun after diagnosis, after multiple adjustment including education:
HR=0.30 (95%CI:0.10-0.87; p=0.03) conclusions: Holidays in the sun were associated with thinner melanomas in
women and reduced rates of relapse in both sexes. However, these results do not prove a direct causal effect of sun
exposure on survival since other confounding factors, such as vitamin D serum levels and socio-economic status,
may play a role. Other factors in sun seeking individuals may also possibly affect these results.
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Introduction
The incidence of CM has steadily increased over the last 30
years in most fair-skinned populations even if the great majority
of the increase has been linked to the increase in diagnoses of
thin lesions with excellent prognosis[1]. One of the hypotheses
for the discrepancy between incidence and mortality trends is
that melanomas are detected at earlier stages in women than
in men[2]. Another hypothesis is that part of melanoma
epidemic is made of non life-threatening melanomas that could
be promoted by sun exposure. Recent sun exposure could be
able to trigger skin cancers with little malignant potential. Long
noted is the relationship between sun exposure and non-
melanoma skin cancer (NMSC) and superficial spreading
melanoma (SSM), which are often not aggressive[3].
This last hypothesis arose from the results of a study
evaluating the association of sun exposure indicators with
melanoma mortality. This American study of 528 melanoma
cases showed that markers of sun exposure were inversely
associated with death from melanoma[4].In this study, we
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investigated if different indicators of UV exposure, collected
before and after CM diagnosis, are associated with Breslow
thickness and recurrence in Italy. We wanted to investigate if
there could be an induction period for the most aggressive
melanoma.
Material and Methods
A hospital-based study of melanoma cases was initiated in
2007 at the European Institute of Oncology in Milan, Italy,
which is a secondary and tertiary centre for CM diagnosis and
treatment. A self-administered questionnaire was given
systematically to all patients during clinics (response rate 99%)
and data was collected on socio-demographic variables,
season of diagnosis and CM site. Skin type was assessed with
the Fitzpatrick classification.
A total of 742 CM patients with histologically confirmed
diagnosis of primary CM without relapse were identified via two
databases: the Institutional Melanoma Database and the
Tumour Registry of the European Institute of Oncology (IEO),
Milan, after informed consent was obtained. Use of the data
included in The IEO Tumour Registry was approved by the IEO
Institutional Review Board (March 2013). Main clinical
information and information on disease history of the patients
are obtained from the Tumor Registry. The European Institute
of Oncology is a tertiary referral centre and assessment of
diagnosis, cancer characteristics and recurrence was made by
highly qualified dermatologists, pathologists, surgeons and
oncologists.
As shown in Figure 1a, there were two cohorts of patients
which did not overlap: cases interviewed at initial diagnosis
(Group 1) and those during follow-up (Group 2), with the same
questionnaire. In the latter group, median time from CM
diagnosis to questionnaire was 2.6 years (1-6 years inter-
quartile range). Sun exposure data for Group 1 was collected
by asking CM patients if they had holidays in the 2 years
preceding their melanoma diagnosis and if yes, how many
weeks of holidays per year for each year. For Group 2 at follow
up, they were asked the same questions for a period of 2 years
before the questionnaire. We asked information on the last 2
years because this is easy to remember and usually these
types of habits before diagnosis do not change. After diagnosis
patients will likely change behaviour[5][6][7] and we made the
same questions for the Group 2. Data on sun exposure during
peak hours (11:00AM-1:00PM) in the previous two years,
sunbed exposure (current use and use before age 30) and
residence of at least one year in tropical countries before age
of 14 was also collected. We used ‘sunny holidays’ as indicator
of high sun exposure because Italians sunbath mainly in
holidays and it is a measure less prone to recall bias. In fact
questions commonly used to measure sun exposure, especially
those reflecting past exposures, embody attempts to recall
events that are subject to both systematic recall bias and
random misclassification[8][9]. Recent sunny holidays will be
less subject to misclassification. Furthermore recall bias
characterize case-controls designs and in our study design
comparing melanoma cases this information should be more
reliable. Sunny holidays will be referred to holidays in the
manuscript.
Patients with previous CM primary, missing histology, in situ,
acral melanoma, mucosal melanoma, vulvar or ano-rectal
melanoma and patients with distant metastases at diagnosis
were excluded (n=51, 7%), leaving 691 patients eligible for the
study: 289 were interviewed at diagnosis (42%, Group 1) and
402 during follow-up (58%, Group2).
For the analyses on CM recurrence, 496 patients with pT1-
T3N0M0 staging were included: 225 interviewed at diagnosis
(group 1) and 271 after diagnosis (group 2). For group 2 we
included patients with a diagnosis of CM at the most 7 years
before the questionnaire, to avoid inclusion of very long
survivors. No residents in other countries were found.
Questions on sun exposure refer to two years before diagnosis
for group 1 and for group 2, for 2 years before the
questionnaire during follow-up. In order to avoid time related
bias, the competing risk analysis in group 2 started from the
time of interview (free of disease). A sensitivity analysis was
carried out including also long survivors.
Statistical methods
Associations between categorical variables at baseline and
median Breslow thickness was evaluated by non-parametric
median two sample tests. Associations between categorical
variables and holidays were evaluated by the Chi-square test,
Fisher exact test and the Chi-square test for trend, as
appropriate.
In multivariate analyses, Breslow thickness was either
analysed as categorical variable or as continuous variable.
Logistic models were used to evaluate the probability to have a
thick CM (Breslow >1mm) and an ANCOVA model was
introduced, transforming Breslow thickness for normal
distribution. All possible confounding factors were evaluated in
multivariate models.
For cumulative incidence, only first events of interest were
considered. For the cumulative incidence of CM-related events,
CM-related recurrences from a primary CM and deaths were
counted as events, while second CM, NMSC and non-CM
primary cancers were considered as competing events, since
they may be associated to a genetic predisposition or other
causes. Follow-up of patients free of events was censored at
the date of last visit. Cumulative incidences were compared
across groups by means of the Gray test. Multivariable Cox
proportional hazards models were applied to evaluate holidays
as independent prognostic factor and assumptions on
proportional hazards were verified. Adjusted hazard ratios (HR)
with 95% confidence intervals (CIs) were reported. All analyses
were carried out with SAS software version 9.2 (SAS Institute,
Cary, NC) and R software, version 2.12.2 (http://www.r-
project.org). All reported p values were two-sided.
Results
Six hundred ninety-one histologically confirmed primary CM,
diagnosed between 1984 and 2012 were eligible for the study.
Median age at diagnosis was 47 years (inter-quartile range:
37–60), 375 (54%) had a thick CM (Breslow>1mm), 378 (55%)
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were women, 519 (75%) had a high level of education (high
school at least) and 449 (65%) lived in Northern Italy. Seventy-
three percent (n=501) had a superficial spreading melanoma
(SSM) and 15% (n=101) nodular melanoma (NM). All potential
Figure 1.  Study design.  
doi: 10.1371/journal.pone.0078820.g001
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factors associated with Breslow thickness are shown in Table
1.
As expected men, older cases (above 60 years) and those
with low levels of education had thicker CM compared to
women, younger and more educated patients, respectively
(Table 1). CMs diagnosed by a dermatologist had a lower
Breslow thickness compared to those detected by general
practitioners or other specialists (median Breslow 1.0 vs.1.5
Table 1. Breslow’s thickness by socio-demographic
characteristics and clinical features.
Feature Categories N
Median Breslow
thickness (IQR) P-value1
Gender Female 378 1.0 (0.5, 1.9) 0.001
 Male 313 1.3 (0.7, 2.4)  
Age>60 years Yes 159 1.6 (0.8, 3.0) <.0001
 No 532 1.0 (0.6, 2.0)  
Education2 At least high school 519 1.0 (0.5, 1.9) <.0001
 No High school 172 1.5 (0.9, 3.0)  
Residence3 Northern Italy 449 1.2 (0.6, 2.4) 0.136
 Central/southernItaly 242 1.0 (0.6, 2.1)  
BMI>25 Yes 291 1.3 (0.6, 2.7) 0.003
 No 400 1.0 (0.6, 1.9)  
Phototype I-II 364 1.2 (0.7, 2.2) 0.029
 III-IV 314 1.0 (0.5, 2.1)  
 Missing 13 2.2 (1.1, 4.0)  
Current smoker Yes 297 1.2 (0.6, 2.4) 0.17
 No 383 1.0 (0.6, 2.0)  
 Missing 11 1.1 (0.6, 3.8)  
Medical visit at
diagnosis Dermatologist 321 1.0 (0.6, 1.8) 0.002
 Other medicaldoctor 106 1.5 (0.6, 3.0)  
 Missing 264 1.1 (0.6, 2.3)  
Season of
diagnosis Summer 188 1.2 (0.7, 2.2) 0.161
 Autumn 182 1.0 (0.5, 2.0)  
 Winter/springtime 321 1.1 (0.6, 2.3)  
Histological type SSM 501 0.9 (0.5, 1.5) <0.0001
 NM 101 3.0 (2.1, 4.3)  
 Other 5 2.3 (2.1, 3.0)  
 Missing 84 1.7 (0.7, 3.0)  
CM family history Yes 35 1.0 (0.6, 2.2) 0.324
 No 458 1.2 (0.7, 2.3)  
 Missing 198 1.0 (0.5, 1.9)  
NMSC personal
history Yes 17 1.1 (0.7, 2.0) 0.927
 No 674 1.1 (0.6, 2.2)  
Other cancer
personal history Yes 15 1.2 (0.9, 2.5) 0.425
 No 676 1.1 (0.6, 2.2)  
P-value from Wilcoxon test, excluding missing values.
BMI: Body Mass Index; CM: Cutaneous Melanoma; NMSC: Non-Melanoma Skin
Cancer. SSM: Superficial Spreading Melanoma. NM: Nodular melanoma
doi: 10.1371/journal.pone.0078820.t001
mm; p=0.002). The female frequency of thick CM was
significantly lower for high education than in low education
(40% vs 71%; p<0.0001), whereas male thickness in men did
not change by education (Figure 1b). In multivariable logistic
models assessing the probability of thick (> 1mm) vs. thin
(≤1mm) CM, after adjusting for age, gender, grade of clinician,
BMI, family history and personal history of NMSC, the
interaction between thickness and education in women
remained significant (p=0.03): a 77% reduction in risk of thick
CM for highly educated women (OR=0.23; 95%CI: 0.12 to
0.45) compared to low educated women, whereas this was not
significant in men (OR=0.67; 95%CI: 0.33 to 1.36).
Frequencies of socio-demographic, clinical features and UV
exposure indicators categorised by holidays, for the 289
patients evaluated at diagnosis, are presented in Table 2.
Patients with higher level of education went more often on
holidays than those with low educational levels (83% vs 65%;
p<0.0001). Ulcerated CM and CM diagnosis during the summer
were more common in those without holidays (Table 2). Slightly
younger subjects were observed in those having holidays but
this did not reach significance (p=0.07).
Breslow categories (pT) were associated with holidays: the
proportion of very thick CM (>4 mm Breslow thickness) was
significantly lower among patients having holidays (8% for
holidays vs 20% for no holidays; p for trend=0.002; Figure 2a).
Very thick melanoma were also negatively associated with
number of weeks of holidays (categorized as ‘no sunny
holidays’, ‘1-2 weeks of sunny holidays per year’, and ‘>2
weeks per year’) in a dose response manner (p for
trend=0.001; Figure 2b).
Median Breslow thickness values are presented in Figure 3a
for several categorical variables possibly associated with UV
exposure. After adjusting for several confounding factors (age,
gender, education, grade of clinician at visit, history of NMSC
and season at diagnosis) holidays before diagnosis remained
significantly associated with lower Breslow thickness (p=0.003).
Exposure during peak hours, history of NMSC, sunbed use and
CM body site, were not significantly associated with Breslow
thickness in multivariate analyses, neither were skin type nor
season of CM diagnosis.
Frequencies of sunny holidays were significantly lower in the
group evaluated during follow-up (72% vs. 62% for Group1 and
Group 2 respectively; P=0.01) compared to the group at
diagnosis as well as sun exposure during peak hours (44% vs.
27%; P<0.0001), whereas sunbed exposure did not change
(11% vs. 10%; p=0.28).
Holidays were also significantly associated with Breslow
thickness in a dose-response manner (p=0.007; Figure 3b). We
found a significant interaction between the effect of holidays
and gender (p=0.004; Figure 3c): women had significantly
lower Breslow thickness if they had a history of holidays
(p=0.0004), whereas for men this protective effect of sun
exposure was not significant (p=0.88).
For CM recurrence, median follow-up was 44 months (range
1-72) for group 1 and 40 months (range 2-75) for group 2.
Melanoma staging was very similar according to holidays, as
well as when comparing group 1 and 2 (Table 3).
Sunny Holidays and Melanoma Prognosis
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Table 2. Proportion of patients by sunny holidays at diagnosis (Group 1).
 Categories Sunny holidays No Sunny holidays  
  206 (100%) 83 (100%) P-value*
Gender Male 101 (49.0) 43 (51.8) 0.669
 Female 105 (51.0) 40 (48.2)  
Age at diagnosis ≤ 60 years 162 (78.6) 57 (68.7) 0.074
 > 60 years 44 (21.4) 26 (31.3)  
Residence Northern Italy 140 (68.0) 63 (75.9) 0.181
 Southern Italy 66 (32.0) 20 (24.1)  
Education At least high school 172 (83.5) 54 (65.1) <0.001
 No High school 34 (16.5) 29 (34.9)  
Phototype I-II 114 (55.3) 43 (51.8) 0.651
 III-IV 87 (42.2) 37 (44.6)  
 missing 5 (2.4) 3 (3.6)  
Breslow ≤1.0 97 (47.1) 29 (34.9) 0.016
 1.1-2.0 mm 55 (26.7) 19 (22.9)  
 2.1-4.0 mm 37 (18.0) 18 (21.7)  
 >4 17 (8.3) 17 (20.5)  
Lymph node involvement Yes 16 (7.8) 11 (13.3) 0.147
 No 190 (92.2) 72 (86.7)  
Ulceration Yes 38 (18.4) 24 (28.9) 0.049
 No 155 (75.2) 54 (65.1)  
 Missing 13 (6.3) 5 (6.0)  
Histology SSM 165 (80.1) 60 (72.3) 0.225
 NM 24 (11.7) 16 (19.3)  
 Other 2 (1.0) 1 (1.2)  
 missing 15 (7.3) 6 (7.2)  
Family history of melanoma Yes 9 (4.4) 3 (3.6) 0.951
 No 137 (66.5) 55 (66.3)  
 Missing 60 (29.1) 25 (30.1)  
Personal history of NMSC Yes 4 (1.9) 5 (6.0) 0.071
 No 202 (98.1) 78 (94.0)  
Grade of clinician at diagnosis Dermatologist 126 (61.2) 48 (57.8) 0.112
 Other doctor 49 (23.8) 15 (18.1)  
 Missing 31 (15) 20 (24.1)  
Melanoma on sun exposed site Yes 40 (19.4) 15 (18.1) 0.827
 No 166 (80.6) 67 (80.7)  
 Missing 0 (0.0) 1 (1.2)  
Holidays in tropical countries Yes 60 (29.1) 16 (19.3) 0.072
 No 138 (67) 65 (78.3)  
 Missing 8 (3.9) 2 (2.4)  
Sun exposure during peak hours (11:00AM- 1:00PM) Yes 103 (50.0) 20 (24.1) <0.001
 No 99 (48.1) 59 (71.1)  
 Missing 4 (1.9) 4 (4.8)  
Sunbed (current user) Yes 18 (8.7) 8 (9.6) 0.813
 No 185 (89.8) 74 (89.2)  
 Missing 3 (1.5) 1 (1.2)  
Sunbed use before age of 30 Yes 48 (23.3) 21 (25.3) 0.759
 No 153 (74.3) 61 (73.5)  
 Missing 5 (2.4) 1 (1.2)  
Season of diagnosis Summer 40 (19.4) 32 (38.6) 0.001
 Autumn 55 (26.7) 12 (14.5)  
 Winter/springtime 111 (53.9) 39 (47.0)  
* P-value from Chi-square or Mantel-Haenszel Chi-Squares for trend, excluding missing values CM: Cutaneous Melanoma; NMSC: Non-Melanoma Skin Cancer. SSM:
Superficial Spreading Melanoma. NM: Nodular melanoma.
doi: 10.1371/journal.pone.0078820.t002
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Overall, six percent of patients had a melanoma recurrence
and 5% a second primary cancer (Table 3).
Holidays before diagnosis was not associated with risk of
recurrence (p=0.64 Gray test; HR=4.19; 95%CI: 0.53 to 33.36
with p=0.18; Figure 4a). However, a significant trend was found
when looking at holidays during follow-up. The 5-year
cumulative incidence of CM recurrences was 8% for those
having holidays after diagnosis compared to 17% for those
without (p=0.07 Gray test; Figure 4b). After adjustment for
gender, Breslow thickness, ulceration and grade of clinician,
the beneficial impact of holidays on relapse after diagnosis was
statistically significant: HR of 0.30 (95%CI: 0.10 to 0.87;
p=0.03). The results were not affected by further adjustment for
age, education and lag time from diagnosis to questionnaire.
Median time from diagnosis to questionnaire in group 2 was
28.8 for those having holidays after diagnosis compared to
29.1 months for those not having holidays respectively.
Including long survivors the difference in recurrence between
exposed and unexposed is even more significant (HR=0.24,
95%CI: 0.07-0.75 and P=0.01). When restricting the analyses
for those with no more than 5 years from diagnosis to
questionnaire within group 2, the hazard ratio still indicated a
Figure 2.  Group 1, at diagnosis.  A) Percentages of each Breslow category by sunny holidays. B) Percentages of very thick CM
(Breslow>4mm) by weeks of sunny holidays.
doi: 10.1371/journal.pone.0078820.g002
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60% reduction in risk of recurrence, even if it lost statistical
significance: HR=0.38 (95%CI: 0.12 to 1.23; p=0.12).
We also found a dose-response relationship between risk of
melanoma recurrence and number of weeks of holidays. The
hazard ratio for up to 2 weeks or more of holidays were:
HR=0.74 (95%CI: 0.16 to 3.45) and HR=0.28 (95%CI: 0.08 to
0.98), respectively, compared to patients not going on holidays.
Discussion
A history of holidays in the sun for 2 years before CM
diagnosis was significantly associated with lower Breslow
thickness with a significant dose response in Italy. Sunny
holidays after CM diagnosis were also associated with lower
rates of CM recurrence. No association was found with sunbed
exposure and sun exposure during peak-hours and we
observed a lower frequencies of sunny holidays after
melanoma diagnosis. Our results may possibly be explained by
Vitamin D serum levels. However, the observed protective
effect of sun exposure in relation to CM thickness reached
statistical significance only among women. Vitamin D serum
levels have been reported to be lower in women compared to
men even in a sunny country like Italy[10].Thinner CM and
lower recurrence rates have previously been linked to higher
vitamin D serum levels[11].Other observational and case-
control studies found a beneficial effect of vitamin D serum
levels on melanoma survival[12-14].It has also been
hypothesised that Vitamin D might have a beneficial influence
Figure 3.  Group 1, at diagnosis.  A) Breslow thickness by UV exposure indicators. B) Breslow thickness by duration of sunny
holidays. C) Breslow thickness by gender and sunny holidays.
doi: 10.1371/journal.pone.0078820.g003
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for total mortality and incidence of different types of cancers, so
this does not apply to melanoma only[15-20].The effect of sun
exposure was independent from known melanoma prognostic
factors as well as skin awareness or screening indicators.
High educational level, that can be considered a proxy for
socio-economic status, was found to be significantly associated
with thin CM but only among women. A limitation of this study
is the lack of information on types of occupation (e.g. indoor
versus outdoor work) and socio-economic status, since
Table 3. Events among low stage melanoma patients (pT1-
T3N0M0) by sunny holidays.
   
Sunny
holidays
n=341
No sunny
holidays
n=155 P-value HR (95%CI)
Group
1 Baseline Breslow
1.0 (0.5,
1.7)
1.0 (0.6,
2.1) 0.59‡  
n=225  Median (Q1,Q3)     
  Ulcerated 26 (17%) 11 (20%) 0.57†  
 At follow-up      
  CMrecurrence 11 (7%) 1 (2%) 0.18¥
4.19
(0.53-33.36)
     (0.64§)  
  
Second
primary
NMSC
3 (2%) 1 (2%)   
  Secondprimary CM 5 (3%) 1 (2%)   
  Othercancer 2 (1%) 1 (2%)   
  Death 3 (2%) 2 (4%) 0.28¥  
Group
2 Baseline Breslow
0.9 (0.5,
1.5)
1.0 (0.5,
1.7) 0.57‡  
n=271  Median (Q1,Q3)     
  Ulceration 14 (9%) 13 (15%) 0.19†  
 At follow-up      
  CMrecurrence 9 (5%) 10 (10%) 0.03¥
0.30
(0.10-0.87)*
     (0.07§)  
  
Second
primary
NMSC
2 (4%) 0 (1%)   
  Secondprimary CM 8 (5%) 3 (3%)   
  Othercancer 2 (1%) 0 (0%)   
  Death 3 (2%) 2 (2%) 0.38¥  
* In group 2 very long survivors were excluded. ¥Cox model adjusted for gender,
Breslow thickness, ulceration and degree of doctor. § Gray test for competing risk
analysis. ‡ Wilcoxon tests for median values; † Chi-square/Fisher exact tests. CM:
Cutaneous Melanoma; NMSC: Non-Melanoma Skin Cancer.
doi: 10.1371/journal.pone.0078820.t003
education can only in part overcome this problem. In fact the
reason why educated females have thinner melanomas could
be that they have a different pattern of sun exposure compared
to men. Male gender has already been reported to be an
independent risk factor for thick CM as well as living
alone[21,22]. Part of the observed increase in CM incidence
over the last 30 years consists in a large part of very thin CM,
which could potentially be promoted by sun exposure. However
this is confounded by increased awareness and screening over
the last 30 years. There is a need to understand what triggers
aggressive CM. Indeed, nodular melanomas are already known
to be less related to sun exposure compared to superficial
spreading types[3].It is important to notice that sunny holydays
are not necessarily associated with sunbathing and and
sunburns, well know risk factors for melanoma[23]. In fact sun
exposure during hot hours and residence in tropical countries
in youth, that are proxy for sunbathing and sunburns more than
sunny holidays, were not found to be associated with CM
prognosis.
Our data confirmed a greater frequency of SSM in patients
going on regular holidays in the sun. However, adjusting for
histology, the effect of UV exposure on CM thickness and
recurrence remained.
A potential bias for the effect of sun exposure on thickness
could be screening bias, We took into account of this looking at
grade of clinician and season of diagnosis. In fact subjects who
had regular holidays in the sun before diagnosis were more
prone to seek dermatological screening as in view of their sun
seeking behaviour or because having naked skin in summer
made them more aware of potentially malignant lesions.
However frequencies of visits to dermatologists were similar in
exposed and unexposed and all the analyses were adjusted for
grade of clinician. Furthermore season of diagnosis, was not
significantly associated with Breslow thickness and CM
diagnosed during summer months were more frequent among
patients with no holidays, which does not suggest a screening
bias.
We know that skin awareness and going on holidays are
linked with education, but sunny holidays were associated with
thickness and melanoma recurrence adjusting for educational
status and skin awareness indicators.
Another selection bias could be that patients who enjoy
outdoor sun exposure are more likely to be in good health,
compared to patients who are older and/or with comorbidities
who may have a higher chance of relapse. However the two
exposure groups have similar initial stage of disease. In order
to avoid time related biases, such as immortal bias, we started
the analysis from the time of the questionnaire. It is still
possible that other unknown protective factors in sun seeking
individuals explained the improved survival.
Despite the fact that there are sources of bias that we were
not able to fully address, we believe that our study shows
several intriguing results that should be further investigated and
are in agreement with previous epidemiological publications un
sun exposure indicators and melanoma survival[4][24][25] It is
also reassuring that results on recurrence are in agreement
with results at baseline: sunny holidays are inversely
associated with worse prognostic factors (thickness and
Sunny Holidays and Melanoma Prognosis
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Figure 4.  Group 1, at diagnosis: cumulative incidence for melanoma recurrence by sunny holidays (A).  Group 2, during
follow-up: cumulative incidence for melanoma recurrence by sunny holidays.
doi: 10.1371/journal.pone.0078820.g004
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ulceration) and recurrence. Furthermore dose-response
relationships are confirmed. Moreover, if major confounders
had biased results, we should have obtained similar results
with other indicators of UV exposure, such as sun exposure
during peak hours and sunbed use, but it was not the case:
only sunny holidays were found to be inversely associated with
CM prognosis.
Solar radiation is a well-established skin carcinogen so the
interpretation of the protective effects of sun exposure on
melanoma needs to be made with caution. These results need
to be confirmed by larger studies with measurements of
Vitamin D serum levels in summer and winter as well as data
on Vitamin D receptor genotypes. In the meantime, there is a
need to be aware of the risk of Vitamin D deficiency in
melanoma patients and we recommend measuring Vitamin D
levels during follow up and offer supplementation if
necessary[26].[19,27]
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